Tianjin Lisheng Pharmaceutical Co Ltd SZSE:002393:
TIANJIN LISHENG PHARMACEUTICAL QTRLY OPERATING INCOME RMB 332.28 MILLION
QTRLY NET PROFIT ATTRIBUTABLE TO OWNERS FOR TIANJIN LISHENG PHARMACEUTICAL RMB 51.88 MILLION
Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
Earlier from Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
- Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
- Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
- Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
- Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co